News
Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.
Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.
The rate of appropriate treatment suggestions was 86.6% for Claude3-Opus, 85.7% for GPT4-Turbo, and 75.0% for LLaMa3-70B. Artificial intelligence (AI) can accurately suggest appropriate adjuvant ...
4d
Pharmaceutical Technology on MSNAstraZeneca’s oral breast cancer drug Truqap greenlit for NHS useAstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, providing a new targeted therapy option that significantly increases ...
4d
GB News on MSN'Landmark moment' as breast cancer pill to be offered on NHS benefiting 'thousands of patients'Thousands of women with advanced breast cancer in England and Wales are to be offered a "gamechanging" twice-a-day pill on ...
A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.
The standard mammogram is sometimes used with breast magnetic resonance imaging (MRI) to detect or rule out breast cancer for people at high risk of the disease. Breast MRIs can detect tumors that ...
Most healthcare professionals treat invasive breast cancers with a combination therapies such as surgery and hormonal therapy or surgery and radiation. An oncologist, or cancer specialist ...
Some changes from taking hormone therapy are permanent and some are reversible if you stop taking your medications. Estrogen treatment can mean softer skin/hair, breast development, and fat and muscle ...
Buckingham Palace has confirmed the King does not have prostate cancer. When the diagnosis was publicly announced, Charles returned from Sandringham to London to start his treatment as an outpatient.
“This type of precision medicine is a game changer for people whose prostate cancer has spread outside of the prostate despite treatment with hormonal therapy,” says Memorial Sloan Kettering Cancer ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The design of the study is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results